article thumbnail

Amgen Abandons Alzheimer's Prevention Study

socalTECH

According to the three, the study of BACE1 inhibitor CNP520 was discontinued, after they concluded the potential benefit for participants in the studies did not outweigh the risk. The companies said that they identified "worsening in some measures of cognitive function" during the Phase 2/3 studies. READ MORE>>.

Study 113
article thumbnail

Cornerstone OnDemand: Time Off To Study Ballot Popular With Employees

socalTECH

Santa Monica-based Cornerstone OnDemand , which develops employee development software, says that a survey it has run has found that 50 percent of employees it surveyed desire time off to study their ballot before they vote. Cornerstone said its survey also found nearly 22% of adult U.S. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: Emerging Technology Clusters Complement Silicon Valley, Others

socalTECH

A new study, which looks at "silicon clusters" of technology companies outside Silicon Valley, finds that those clusters actually stimulate rather than compete with developed market clusters. The study--published by Professor Nukhet Harmancioğlu (Koc University, Turkey) and Gerard J.

Study 127
article thumbnail

Study: Cybersecurity Industry Growing In San Diego

socalTECH

A nonprofit organization focused on promoting cybersecurity and related jobs in San Diego, the Cyber Center of Excellence , says it has commissioned a study which has found that cybersecurity related jobs have grown in San Diego by 11 percent since 2016, with the industry generating $2.2 billion in GDP.

San Diego 113
article thumbnail

Hyperloop TT: Study Shows Great Lakes Hyperloop Will Be Profitable

socalTECH

Playa Vista-based advanced transportation technology developer Hyperloop Transportation Technologies , one of the companies working on the Hyperloop transportation concept first devised by Elon Musk, says that a study--conducted in Ohio--shows one of its proposed routes "is profitable and makes sense". READ MORE>>.

Study 100
article thumbnail

Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold

Xconomy

A Phase 1 trial testing a Poseida Therapeutics cell therapy in men with prostate cancer is on hold after a patient enrolled in the study died of liver failure nearly three weeks after receiving the treatment.

Study 107
article thumbnail

Amgen Reports Positive Results In Ostereoposis Study

socalTECH

Thousand Oaks-based Amgen reports that it saw positive top-line results for a study for its romosozumab compound in men with osteoporosis. Amgen said its Phase 3 study demonstrated a significant increase in bone mineral density (BMD) at the lumbar spine, compared with a placebo over 12 months.

Study 100